1 January 2024 false Taxfiler 2024.6 14574842business:PrivateLimitedCompanyLtd2024-01-012024-12-31 145748422023-12-31 145748422024-01-012024-12-31 14574842business:AuditExemptWithAccountantsReport2024-01-012024-12-31 14574842business:FilletedAccounts2024-01-012024-12-31 145748422024-12-31 14574842business:Director12024-01-012024-12-31 14574842business:RegisteredOffice2024-01-012024-12-31 145748422023-12-31 14574842core:WithinOneYear2024-12-31 14574842core:WithinOneYear2023-12-31 14574842core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 14574842core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 14574842core:SharePremiumcore:PreviouslyStatedAmount2024-12-31 14574842core:SharePremiumcore:PreviouslyStatedAmount2023-12-31 14574842core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 14574842core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 14574842core:PreviouslyStatedAmount2024-12-31 14574842core:PreviouslyStatedAmount2023-12-31 14574842business:SmallEntities2024-01-012024-12-31 14574842countries:EnglandWales2024-01-012024-12-31 14574842core:ComputerEquipment2024-01-012024-12-31 14574842core:ComputerEquipment2023-12-31 14574842core:ComputerEquipment2024-12-31 145748422023-01-062023-12-31 iso4217:GBP xbrli:pure
Company Registration No. 14574842 (England and Wales)
Nova Biochem Ltd Unaudited accounts for the year ended 31 December 2024
Nova Biochem Ltd Unaudited accounts Contents
Page
- 2 -
Nova Biochem Ltd Company Information for the year ended 31 December 2024
Director
Dr Alexander Novitskiy
Company Number
14574842 (England and Wales)
Registered Office
Flat 33 Anchorage Point 42 Cuba Street London E14 8NE England
Accountants
Lanamak Finance Ltd 128 City Road London EC1V 2NX
- 3 -
Nova Biochem Ltd Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Tangible assets
5,630 
990 
Current assets
Debtors
57,559 
26,359 
Cash at bank and in hand
90,871 
271,514 
148,430 
297,873 
Creditors: amounts falling due within one year
(2,998)
(8,171)
Net current assets
145,432 
289,702 
Net assets
151,062 
290,692 
Capital and reserves
Called up share capital
1 
1 
Share premium
449,999 
449,999 
Profit and loss account
(298,938)
(159,308)
Shareholders' funds
151,062 
290,692 
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 18 January 2025 and were signed on its behalf by
Dr Alexander Novitskiy Director Company Registration No. 14574842
- 4 -
Nova Biochem Ltd Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Nova Biochem Ltd is a private company, limited by shares, registered in England and Wales, registration number 14574842. The registered office is Flat 33 Anchorage Point, 42 Cuba Street, London, E14 8NE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% on cost
Government grants
Government grants in relation to tangible fixed assets are credited to profit and loss account over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to profit and loss.
Research and development
Expenditure on research and development is written off in the year in which it is incurred.
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 January 2024
1,320 
Additions
5,492 
At 31 December 2024
6,812 
Depreciation
At 1 January 2024
330 
Charge for the year
852 
At 31 December 2024
1,182 
Net book value
At 31 December 2024
5,630 
At 31 December 2023
990 
- 5 -
Nova Biochem Ltd Notes to the Accounts for the year ended 31 December 2024
5
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
10,711 
26,359 
Other debtors
46,848 
- 
57,559 
26,359 
6
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
2,165 
7,338 
Accruals
833 
833 
2,998 
8,171 
7
Average number of employees
During the year the average number of employees was 2 (2023: 1).
- 6 -